Option Care Health stock analysis
Option Care Health (OPCH) Stock Price & Analysis
OPCH Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- CHF 3.98B
- Enterprise Value
- CHF 4.35B
- Total Cash (Recent Filing)
- CHF 299.09M
- Total Debt (Recent Filing)
- CHF 1.26B
- Price to Earnings (P/E)
- 22.8
- Beta
- N/A
- Next Earnings
- Feb 25, 2027 (Est.)
- EPS Estimate
- 0.45
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Sustained Revenue Growth
Multi-year revenue expansion demonstrates continued demand for Option Care Health’s alternate-site infusion model and increasing scale. Growth across a larger operating base can support broader clinical coverage, strengthen payer and provider relationships, and provide a foundation for durable earnings generation.
Clinic Expansion And Therapy Growth
Expanding ambulatory capacity and rising clinic utilization indicate that the company is deepening its alternate-site care platform. Growth across multiple therapy categories and patient volumes can diversify demand and reinforce Option Care’s position in specialty infusion delivery.
Positive Cash Generation And Cost Control
Strong quarterly operating cash flow, combined with lower SG&A as a percentage of revenue, shows the business can convert operations into funding while controlling overhead. These capabilities support investment in clinics, technology, and commercial resources without relying solely on external financing.
Bears Say
Margin Compression
The decline in gross, operating, and net margins indicates that revenue growth is not translating into profits at the earlier rate. Persistently thinner margins would reduce resilience to reimbursement or mix changes and limit the cash available for investment and debt reduction.
CID Portfolio Headwinds
The chronic inflammatory portfolio is expected to remain a material drag on both revenue and gross profit during 2026. This pressure can offset growth in acute, neuro, and rare therapies, making the company more dependent on successful portfolio replacement and execution.
Elevated Leverage
A higher debt-to-equity profile reduces financial flexibility relative to a more conservatively financed balance sheet. Leverage can constrain capital allocation, increase sensitivity to operating setbacks, and make it harder to fund expansion or absorb prolonged margin pressure internally.
Option Care Health News
OPCH FAQ
What is Option Care Health’s market cap?
When is Option Care Health’s upcoming earnings report date?
How were Option Care Health’s earnings last quarter?
Is Option Care Health overvalued?
Does Option Care Health pay dividends?
What is Option Care Health’s EPS estimate?
What happened to Option Care Health’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Option Care Health?
What is the TipRanks Smart Score and how is it calculated?
Option Care Health Stock Smart Score
Company Description
Option Care Health
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- John C. Rademacher
- Employees
- 6,528
- Website
- www.optioncarehealth.com
- Address
- 3000 Lakeside Drive, Bannockburn, IL, 60015, US
Option Care Health (OPCH) Earnings & Revenues
OPCH Earnings Call
Earnings Call SentimentNeutral
The call presented a balance of meaningful operational and financial positives — including sequential revenue and EBITDA growth, strong cash generation ($184M in Q2), active share repurchases ($150M), clinic expansion, and progress in key portfolios (acute, IG neuro, rare/orphan) — while acknowledging persistent headwinds tied to the CID portfolio that are expected to depress 2026 revenue (~600 bps) and gross profit (~$55M). Management emphasized execution of commercial, technology and cost initiatives to drive sequential improvement through the back half of the year, but several initiatives and new therapy launches carry timing and execution risk.
View all CH:OPCH earnings summaries










